Nasdaq-listed MEI Pharma starts $100M Litecoin plan, shares soar 50% post-announcement.
- MEI Pharma launches $100M Litecoin treasury plan with Charlie Lee on board.
- MEIP stock rises 50% after announcement.
- First US-listed company holding LTC as a treasury asset.
Nasdaq-listed MEI Pharma announced a $100M Litecoin treasury initiative, seeing a 50% increase in stock value.
The move signifies the first publicly traded company to exclusively adopt Litecoin, affecting market sentiments and LTC’s position.
MEI Pharma’s $100 Million Litecoin Bet Unveiled
MEI Pharma’s $100M Litecoin initiative marks a significant shift in corporate crypto adoption. Charlie Lee, Litecoin’s creator, joins the board, highlighting the initiative’s importance.
The strategy involves GSR managing the Litecoin treasury. MEI Pharma becomes the first firm exclusively using LTC for its treasury among publicly traded companies.
MEIP Stock Surges 50% Following Litecoin Strategy Announcement
MEI Pharma’s stock saw immediate volatility, with near 95% growth before stabilizing. Investor enthusiasm was reflected in trading volumes.
Financial implications include improved liquidity and visibility for Litecoin. This strategic approach could prompt a shift in how companies manage digital assets.
Litecoin Treasury Move Mirrors MicroStrategy’s BTC Strategy
Comparable moves include MicroStrategy’s BTC acquisitions, indicating potential long-term value strategies for crypto treasuries.
Experts suggest that this strategy might continue to influence market perceptions and investments, potentially inciting other firms to explore crypto-treasury models.
Charlie Lee, Creator of Litecoin, said, “For 14 years, Litecoin has consistently delivered a stable, low-cost, and accessible network for millions… This partnership with GSR and MEI Pharma brings that utility and mission into an institutional setting for the first time.”
| Disclaimer: The information on this website is for informational purposes only and does not constitute financial or investment advice. Cryptocurrency markets are volatile, and investing involves risk. Always do your own research and consult a financial advisor. |
